U.S. federal trademark · Serial No. 88622674 · Reg. No. 7380913
Research and development services in the field of biologics, namely, antibodies and peptides for the treatment of cancer and immunotherapies; research and development in the pharmaceutical and biotechnology fields for the treatment of cancer and immunotherapies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials in the field of cancer and immunotherapies; consulting services in the fields of biotechnology, pharmaceutical research and development, and pharmacogenetics in the field of cancer and immunotherapies; conducting research for others in the field of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics in the field of cancer and immunotherapies
Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders, all of the foregoing excluding treatments for neuromuscular disorders and orphan diseases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.